It is now well established that there are several main breast cancer subtypes: estrogen receptor (ER) positive and/or progesterone receptor positive; human epidermal receptor 2 (HER2) amplified; and a third group that does not express any of the receptors above, referred as triple-negative breast cancer [2]. Here, ERBB2 is linked to breast cancer.